# Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

> **NCT00104780** · PHASE2 · UNKNOWN · sponsor: **Epimmune**

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** EP-2101
- **BIOLOGICAL:** incomplete Freund's adjuvant

## Key facts

- **NCT ID:** NCT00104780
- **Lead sponsor:** Epimmune
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104780, "Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00104780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*